Skip to main content
. 2020 Jul 30. Online ahead of print. doi: 10.1016/j.hemonc.2020.07.005

Table 2.

Biochemical outcomes in cancer versus non-cancer groups infected with COVID-19.

Biochemical outcome n Effect estimate (IV, fixed)
Platelets (×109/L) 24 −186.66 (−222.62, −150.70)
D-Dimer (mg/L) 24 0.37 (0.06, 0.68)
C-reactive protein (mg/L) 24 73.44 (37.61, 109.27)
Procalcitonin (ng/mL) 24 1.82 (0.50, 3.15)
Prothrombin time (s) 24 3.00 (1.72, 4.28)

Note. Data presented are the mean difference, 95% confidence interval of the comparison between cancer and non-cancer patients. Analysis was conducted under the fixed effect model, inverse variance method.